Roberto Sorasio - Dept Neurol, S Croce & Carle Hosp

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 106 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Venetoclax Plus Decitabine As a Bridge to Allogeneic Haematopoietic Stem-Cell Transplantation in Older Patients with Acute Myeloid Leukaemia (VEN-DEC GITMO): Final Report of a Multicentre, Single-Arm, Phase 2 Trial

LANCET HAEMATOLOGYno. 11 (2024): E830-E838

Cited1Views0WOSBibtex

Supplementary Figure 1 from Phase II Study of Perifosine and Sorafenib Dual-Targeted Therapy in Patients with Relapsed or Refractory Lymphoproliferative Diseases

Anna Guidetti,Carmelo Carlo-Stella,Silvia L. Locatelli,Walter Malorni,Roberta Mortarini,Simonetta Viviani,Domenico Russo,Alfonso Marchianò,Roberto Sorasio,Anna Dodero,Lucia Farina,Laura Giordano,Massimo Di Nicola,Andrea Anichini,Paolo Corradini,Alessandro M. Gianni

openalex（2023）

Cited0Views0Bibtex

Baseline‐PET Derived Metrics Are the Most Relevant Factors for Risk Stratification in Early‐stage Nonbulky HL: Preliminary Results of the RAFTING Trial

J. M. Zaucha,M. Picardi,M. Kurlapski,C. Patti,E. Domingo‐Domenech,R. Garcia Sanz, A. Rossi,J. Lopez‐jimenez,L. Trentin,M. Gotti,S. Viviani,R. Sorasio,A. Giza, C. Martinez‐Munoz, J. Nunez‐Cespedes,K. Filonenko,S. Chauvie, L. Guerra,A. Rambaldi,A. Sureda,A. Gallamini

Hematological Oncology（2023）

Cited0Views0Bibtex

Supplementary Tables from Phase II Study of Perifosine and Sorafenib Dual-Targeted Therapy in Patients with Relapsed or Refractory Lymphoproliferative Diseases

openalex（2023）

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn